Dr. Leah T. Belazarian, MD

Dr. Belazarian practices at Umass Memorial Medical Center in Mendon, Massachusetts.

Dr. Belazarian's NPI, 1598814311, was assigned on January 10, 2007. Dr. Belazarian graduated from University of Massachusetts Medical School in 2003. Dr. Belazarian holds Massachusetts license 231813.

Dr. Belazarian's primary practice is Umass Memorial Medical Center, at 55 North Ave, Mendon, MA 01756 in Worcester County. The practice phone is (508) 334-1000.

Dr. Belazarian's primary practice is Umass Memorial Medical Center in Mendon, Massachusetts. Dr. Belazarian is also affiliated with UMass Memorial Medical Center - University Campus. The medical group on file is UMass Memorial Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Belazarian practices. Vendor and product names are available with a free account.

Dermatology is Dr. Belazarian's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Belazarian is licensed in Massachusetts.

CMS data shows 509 Medicare services from Dr. Belazarian across 6 procedure codes in 2024, for 191 Medicare patients. Medicare paid $18,860 for them. Every service was in an office.

CMS counts 191 Medicare patients who saw Dr. Belazarian in 2024. The largest group is 65 to 74, with 88 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Belazarian's median patient age at 69, with 64% women.

In 2024, Dr. Belazarian wrote 298 Medicare Part D claims for 79 patients. 72% of them were for generic drugs. CMS names the drug for 162 of them, across 8 drugs with 11 or more claims each, at $155,690 in total drug cost. In 2023, CMS named 91 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Belazarian for performance year 2024, reported through an alternative payment model (APM). Dr. Belazarian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 104 procedures of removal of skin lesions by Dr. Belazarian, more than 75% of the clinicians it reports for that procedure.

Dmand AI links 17 papers to Dr. Belazarian, published from 2014 to 2025. 2023 was the busiest year, with 4. The most frequent topics are Skin Neoplasms, Magnetic Resonance Imaging and Nevus, Pigmented. Dr. Belazarian has published most often in Pediatr Dermatol. Dr. Belazarian's most frequent co-authors are Karen Wiss, MD, Isabella Plumptre, MD and Elena Balestreire Hawryluk, MD, PhD.

CMS Open Payments shows 10 general payments to Dr. Belazarian from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. ShockWave Medical, Inc paid the most, $236.

Dr. Belazarian graduated from University of Massachusetts Medical School in 2003.